Enanta Pharmaceuticals Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
101,480.00
90,764.00
145,205.00
210,084.00
223,669.00
308,730
Total Accounts Receivable
1,592.00
4,494.00
15,722.00
12,841.00
10,614.00
67,205
Other Current Assets
1,641.00
12,717.00
9,714.00
9,231.00
3,536.00
4,454
Total Current Assets
104,713.00
107,975.00
170,641.00
232,156.00
237,819.00
380,389
Net Property, Plant & Equipment
1,121.00
1,803.00
5,886.00
8,004.00
8,049.00
8,374
Total Investments and Advances
11,139.00
41,439.00
64,846.00
32,727.00
70,646.00
16,997
Total Assets
116,973.00
155,415.00
246,013.00
281,356.00
327,851.00
415,170
ST Debt & Current Portion LT Debt
-
-
69.00
73.00
79.00
Accounts Payable
1,481.00
1,874.00
1,543.00
3,377.00
3,714.00
Income Tax Payable
-
-
1,199.00
-
9,298.00
Other Current Liabilities
3,045.00
2,872.00
3,893.00
4,439.00
7,891.00
Total Current Liabilities
4,526.00
4,746.00
6,704.00
7,889.00
20,982.00
Long-Term Debt
-
-
692.00
617.00
1,141.00
Provision for Risks & Charges
48.00
76.00
556.00
888.00
1,355.00
Deferred Taxes
-
4,198.00
4,640.00
8,390.00
10,123.00
Other Liabilities
1,931.00
1,737.00
1,904.00
1,947.00
1,483.00
Total Liabilities
6,505.00
6,559.00
9,856.00
11,420.00
26,175.00
Common Equity (Total)
110,468.00
148,654.00
236,157.00
269,936.00
301,676.00
Total Shareholders' Equity
110,468.00
148,856.00
236,157.00
269,936.00
301,676.00
Total Equity
110,468.00
148,856.00
236,157.00
269,936.00
301,676.00
Liabilities & Shareholders' Equity
116,973.00
155,415.00
246,013.00
281,356.00
327,851.00
Preferred Stock (Carrying Value)
-
202.00
-
-
-
About Enanta Pharmaceuticals
View Profile
